Search by Drug Name or NDC

    NDC 23155-0532-05 ETHOSUXIMIDE 250 mg/1 Details

    ETHOSUXIMIDE 250 mg/1

    ETHOSUXIMIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is ETHOSUXIMIDE.

    Product Information

    NDC 23155-0532
    Product ID 23155-532_b7244494-bae5-4434-9b8f-d5ed6d33619a
    Associated GPIs 72400010000105
    GCN Sequence Number 004554
    GCN Sequence Number Description ethosuximide CAPSULE 250 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 17420
    HICL Sequence Number 001891
    HICL Sequence Number Description ETHOSUXIMIDE
    Brand/Generic Generic
    Proprietary Name ETHOSUXIMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ETHOSUXIMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name ETHOSUXIMIDE
    Labeler Name Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA200892
    Listing Certified Through 2024-12-31

    Package

    NDC 23155-0532-05 (23155053205)

    NDC Package Code 23155-532-05
    Billing NDC 23155053205
    Package 500 CAPSULE in 1 BOTTLE (23155-532-05)
    Marketing Start Date 2015-09-09
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 0d0965f7-d780-4d1c-8ecf-77387483cc02 Details

    Revised: 12/2021